Parkside Investments, LLC Bausch Health Companies Inc. Transaction History

Parkside Investments, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$7.06 - $23.63 $1.22 Million - $4.08 Million	-172,500 Reduced 69.44%	75,925 $634,000
Q1 2022 May 02, 2022	BUY	$21.6 - $27.79 $471,960 - $607,211	21,850 Added 9.64%	248,425 $5.68 Million
Q4 2021 Jan 18, 2022	BUY	$23.0 - $29.01 $29,325 - $36,987	1,275 Added 0.57%	226,575 $6.26 Million
Q3 2021 Oct 21, 2021	BUY	$25.04 - $30.06 $1.06 Million - $1.27 Million	42,150 Added 23.01%	225,300 $6.27 Million
Q2 2021 Jul 29, 2021	SELL	$27.43 - $32.7 $1.23 Million - $1.46 Million	-44,775 Reduced 19.64%	183,150 $6.25 Million
Q1 2021 Apr 14, 2021	SELL	$21.37 - $34.38 $5,876 - $9,454	-275 Reduced 0.12%	227,925 $7.23 Million
Q4 2020 Jan 13, 2021	BUY	$15.31 - $21.12 $2.96 Million - $4.08 Million	193,200 Added 552.0%	228,200 $4.75 Million
Q2 2020 Jul 23, 2020	BUY	$13.31 - $20.51 $133,100 - $205,100	10,000 Added 40.0%	35,000 $640,000
Q4 2019 Jan 27, 2020	BUY	$18.89 - $31.89 $20,779 - $35,079	1,100 Added 4.6%	25,000 $748,000
Q3 2019 Nov 06, 2019	BUY	$20.88 - $25.66 $37,584 - $46,188	1,800 Added 8.14%	23,900 $522,000
Q2 2019 Aug 02, 2019	BUY	$20.52 - $26.45 $453,492 - $584,545	22,100 New	22,100 $557,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Parkside Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Parkside Investments, LLC with notifications on news.